abstract |
The invention involves methods and formulations for treating or preventing rhinosinusitis, including fungal-induced rhinosinusitis in mammals. In one embodiment, the formulation of the present invention comprises a steroidal anti-inflammatory agent that has a specific particle size distribution profile. The formulation may also comprise an antifungal agent, antibiotic or antiviral agent. |